Eating Disorder Examination Interview

The Eating Disorder Examination Interview (EDE) is a semi-structured interview conducted by a clinician that has been modified to reflect the current DSM-5 diagnosis. The EDE is rated using four subscales; restraint, eating concern, shape concern and weight concern. Patients are asked about the frequency of their eating disorder behaviours over a 28-day period.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account

Find out more about Eating Disorder Examination

Alternative name
EDE

Active? Yes

First used: 13 October 2021

Related Topic

Eating Disorders
The two most common eating disorders are anorexia nervosa and bulimia nervosa, affecting roughly 16 million people globally. Current medications have limited success in treating people with these disorders. Research with psychedelics including MDMA and psilocybin to treat these disorders is underway.

Related Trials

A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders (MED1)
This Phase II trial with 18 participants will investigate the safety and feasibility of using MDMA-AT for eating disorders (anorexia nervosa & binge eating disorder).

A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
This Phase 2, open-label, multi-site study will explore the safety and feasibility of MDMA-assisted psychotherapy and adjunctive caregiver involvement in the treatment of 18 participants with eating disorders.

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
The primary aim of this study is to assess the safety and tolerability of one 25 mg dose of psilocybin in participants with anorexia nervosa based on adverse events (AEs), changes in vital signs, electrocardiograms (ECGs) and clinical laboratory tests. The secondary objectives are to explore the efficacy of a single 25 mg dose of psilocybin on eating disorder symptoms and behaviors, body image, anxiety, food related obsessions and rituals, and body weight.

Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
The primary aim of this study is to assess the acceptability and efficacy of treating anorexia nervosa with psilocybin. The secondary aim of this study is to use Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG) to examine the neuronal underpinnings of treatment with psilocybin in this patient group.

Effects of Psilocybin in Anorexia Nervosa
The investigators will also assess a number of exploratory measures related to eating disorder pathophysiology.

0 Comments
Inline Feedbacks
View all comments